News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
326
Sources here
27
Companies here
12
Search results Stored financial headlines

Active search

326 matching headlines

Ticker or company: FRESMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Fresenius Medical Care AG (FMS) (Q2 2026) Earnings Call Highlights: Strong Profit Growth and ...

This article first appeared on GuruFocus. Revenue: Solid organic group revenue growth of 5% in Q2, with a 4% increase at constant currency. Operating Income: Increased significantly by 23% at constant currency, with growth accelerating and in line with planned phasing for 2026. Operating …

FMEN main company FMS main company FME main company
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6% FMEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FRPT|Freshpet Inc|Price:62.440|Chg%:+2.820

Freshpet Inc (FRPT) shows strong fundamentals and high growth potential, with its valuation considered fair within the Food & Tobacco industry. Analysts rate the stock as a "Buy" with a target price of $78.67, suggesting a 32.12% upside. Despite some technical indicators suggesting sideways …

FRPT main company
Sharemaestro market context Price above Trend Line 52 weeks +16.2% · Next-week setup positive 56.1% FRPT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Medical Care Shares Slide Despite Second-Quarter Earnings Beat

Researcher looking through microscope ©Adobe Stock Images Fresenius Medical Care (NYSE:FMS) shares fell 8.0% to €41.285 during Tuesday's trading session as investors looked beyond better-than-expected second-quarter results and focused instead on continued weakness in U.S. patient treatment volumes. Although the dialysis provider exceeded analyst …

FMEN main company FMS main company FME main company
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6% FMEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an

FRE main company FRE main company
Sharemaestro market context Price above Trend Line 52 weeks +1.5% · Next-week setup positive 59.6% FRE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Del Monte Foods makes Pittsburgh central hub

Del Monte Foods has designated Pittsburgh as its central operational hub, expanding its presence in the city which began in 2002. This move consolidates core functions like commercial operations, finance, supply chain, and R&D in Pittsburgh, along with senior leadership. The company's chairman and …

FDP main company
Sharemaestro market context Price below Trend Line 52 weeks -15.0% · Next-week setup positive 57.3% FDP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Freshworks Inc. (FRSH) CFO has 10,734 shares withheld to cover taxes

Freshworks Inc. CFO Tyler Sloat had 10,734 shares of Class A common stock withheld on August 1, 2026, to cover tax obligations from RSU vesting. The shares were valued at $11.355 each, and after this transaction, Sloat directly holds 1,746,218 shares. This Form 4 …

FRSH main company
Sharemaestro market context Trend signal active 52 weeks -9.4% · Next-week setup negative 44.5% FRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market

U.S. FDA approves rituximab biosimilar candidate developed by Dr. Reddy's Laboratories (DRL), a biosimilar to Rituxan® (rituximab) Rituximab is a CD20-directed cytolytic antibody used across multiple oncology and immunology indications Approval expands Fresenius Kabi's U.S. biosimilars portfolio and reinforces its commitment to improving access …

FRE main company
Sharemaestro market context Price above Trend Line 52 weeks +1.5% · Next-week setup positive 59.6% FRE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Medical Care GAAP EPS of EUR0.81, revenue of EUR4.86B

* Fresenius Medical Care press release [https://seekingalpha.com/pr/20604629-fresenius-medical-care-accelerates-income-growth-to-23-percent-in-the-second-quarter-of-2026] (FMS [https://seekingalpha.com/symbol/FMS]): Q2 GAAP EPS of EUR0.81. * Revenue of EUR4.86B. MORE ON FRESENIUS MEDICAL CARE * Fresenius Medical Care: More Favorable Patient Outcomes Will Drive Growth [https://seekingalpha.com/article/4923734-fresenius-medical-care-more-favorable-patient-outcomes-will-drive-growth] * Fresenius Medical: High Yield, Utilities-Like Stock At Valuation …

FMEN main company FMS main company FME main company
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6% FMEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Medical Care appoints McLean to management board By Investing.com

Fresenius Medical Care AG has appointed Cassie McLean to its Management Board as Chief Executive Officer of the Care Delivery operating segment, effective immediately. McLean, 48, previously served as President of Fresenius Kidney Care and will now oversee the global clinic business. She replaces …

FMS main company
Sharemaestro market context Trend signal active 52 weeks -3.4% FMS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery

BAD HOMBURG, Germany, Aug. 3, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, has appointed Cassie McLean (48) as a member of the Management Board, effective 1 August …

FMEN main company FMS main company FME main company
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6% FMEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Weekly Recap: Revenue beat, enterprise adds and Ryan Manning named CPTO

Freshworks, Inc. (FRSH) reported a strong Q4 with revenue of $228.6M, beating expectations and showing a 16.5% year-over-year increase, alongside the addition of 326 new enterprise customers. The company also announced the appointment of Ryan Manning as Chief Product & Technology Officer, who will …

FRSH main company
Sharemaestro market context Trend signal active 52 weeks -9.4% · Next-week setup negative 44.5% FRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context